An immunotherapy approach to treating advanced Hodgkin lymphoma may drastically increase patients’ chances of survival, including those as young as 12, according to a new clinical trial.

Jenna Cottrell is a young sports reporter working for a TV station in the Rochester, N.Y., area. She's also a survi ...

John Murphy, of Indian Head, Maryland, shared his story with WTOP about going back to work after two cancer diagnoses while ...

The American Cancer Society estimates that more than 8,000 cases will be diagnosed in the United States this year, and about 900 people will die from the disease. Hodgkin lymphoma can develop at ...

A treatment that rallies the immune system to destroy cancer raised the survival rate for advanced Hodgkin lymphoma patients ...

Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen. This is compared to 83% ...

Ironwood held an event bringing together current patients, survivors, and medical professionals in Scottsdale on Saturday.

Immunotherapy has set a new standard in treating Hodgkin lymphoma, showing a 92% survival rate and fewer long-term side effects, with FDA approval anticipated soon. A new treatment that activates the ...

This year, nearly 10,000 children age 15 and younger in the U.S. are expected to be diagnosed with cancer. As these children ...